Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions

Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions

Bibliographic Details
Main Authors:	Cristina Bottino, Thierry Walzer, Angela Santoni, Roberta Castriconi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Immunology
Subjects:	NK cells ILC NKG2D activating receptor epigenetic mechanisms chemokine receptors NK cell metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.631712/full

Similar Items

NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
by: Stefano Regis, et al.
Published: (2020-02-01)

Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cells
by: Eugene Park, et al.
Published: (2019-08-01)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
by: Christine Koch, et al.
Published: (2017-11-01)

Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy
by: Elisa eMontaldo, et al.
Published: (2016-01-01)

Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease
by: David Goldeck, et al.
Published: (2022-12-01)

JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
by: Laura Vian, et al.
Published: (2019-12-01)

Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1
by: Beatrice Casu, et al.
Published: (2019-01-01)

Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)

Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells
by: Sabrina Bianca Bennstein, et al.
Published: (2020-07-01)

NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
by: Eleonora Russo, et al.
Published: (2021-12-01)

Plasticity of NK cells in Cancer
by: Dillon Corvino, et al.
Published: (2022-05-01)

Circulating CCR6+ ILC proportions are lower in multiple sclerosis patients
by: Florentina Aglas‐Leitner, et al.
Published: (2022-01-01)

The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype
by: Antonia O. Cuff, et al.
Published: (2019-09-01)

Dazed and Confused: NK Cells
by: Timothy E. O'Sullivan
Published: (2019-09-01)

Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes
by: Eva M. García-Cuesta, et al.
Published: (2017-04-01)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans
by: Wiebke Naujoks, et al.
Published: (2020-09-01)

NKG2D and Its Ligands: “One for All, All for One”
by: Alessandra Zingoni, et al.
Published: (2018-03-01)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)

Nanoscale Colocalization of NK Cell Activating and Inhibitory Receptors Controls Signal Integration
by: David Tomaz, et al.
Published: (2022-06-01)

Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
by: Monica Parodi, et al.
Published: (2018-10-01)

Natural Killer Cells and Neuroblastoma: tumor recognition, escape mechanisms and possible novel immunotherapeutic approaches
by: Cristina eBottino, et al.
Published: (2014-02-01)

Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
by: Laura Damele, et al.
Published: (2018-10-01)

Structural basis for recognition of cellular and viral ligands by NK cell receptors
by: Roy eMariuzza, et al.
Published: (2014-03-01)

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
by: Dhanashree Murugan, et al.
Published: (2022-11-01)

NK cells blur the frontier between innate and acquired immunity.
by: Ennio eCarbone, et al.
Published: (2013-01-01)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
by: V. A. Mikhailova, et al.
Published: (2017-01-01)

Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
by: Tiziano Ingegnere, et al.
Published: (2019-04-01)

NK cells during dengue disease and their recognition of dengue virus-infected cells
by: Davis Alexander Beltrán, et al.
Published: (2014-05-01)

Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers
by: Zhi Zhang, et al.
Published: (2021-12-01)

Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention
by: Rosa Molfetta, et al.
Published: (2019-10-01)

HUMAN NK CELLS: FROM SURFACE RECEPTORS TO THE THERAPY OF LEUKEMIAS AND SOLID TUMORS
by: LORENZO eMORETTA, et al.
Published: (2014-03-01)

The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation
by: Silvina Romero-Suárez, et al.
Published: (2019-10-01)

EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34<sup>+</sup> Cells
by: Laura Damele, et al.
Published: (2021-01-01)

Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow
by: Giovanni eBernardini, et al.
Published: (2013-01-01)

Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B
by: Frederik Fabian Feigl, et al.
Published: (2023-02-01)

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
by: Paolo Sportoletti, et al.
Published: (2021-06-01)

Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer
by: Michela Calvi, et al.
Published: (2022-05-01)

IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance
by: Hui Sun, et al.
Published: (2021-03-01)

Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligationResearch in context
by: Mieszko Lachota, et al.
Published: (2023-10-01)

Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis
by: Cui Tu, et al.
Published: (2024-01-01)